In last trading session, Unicycive Therapeutics Inc (NASDAQ:UNCY) saw 1.27 million shares changing hands with its beta currently measuring 2.23. Company’s recent per share price level of $0.61 trading at $0.01 or 2.42% at ring of the bell on the day assigns it a market valuation of $63.30M. That closing price of UNCY’s stock is at a discount of -198.36% from its 52-week high price of $1.82 and is indicating a premium of 67.21% from its 52-week low price of $0.20.
For Unicycive Therapeutics Inc (UNCY), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.07 in the current quarter.
Unicycive Therapeutics Inc (NASDAQ:UNCY) trade information
Upright in the green during last session for gaining 2.42%, in the last five days UNCY remained trading in the green while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $0.61 price level, adding 6.15% to its value on the day. Unicycive Therapeutics Inc’s shares saw a change of -23.21% in year-to-date performance and have moved 14.73% in past 5-day. Unicycive Therapeutics Inc (NASDAQ:UNCY) showed a performance of -6.70% in past 30-days.
Unicycive Therapeutics Inc (UNCY) estimates and forecasts
This year revenue growth is estimated to fall -100.00% from the last financial year’s standing.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -77.09% during past 5 years.
Unicycive Therapeutics Inc (NASDAQ:UNCY)’s Major holders
VIVO CAPITAL, LLC is the top institutional holder at UNCY for having 3.47 million shares of worth $1.74 million. And as of 2024-06-30, it was holding 9.9395 of the company’s outstanding shares.
The second largest institutional holder is LOGOS GLOBAL MANAGEMENT LP, which was holding about 3.47 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.9389 of outstanding shares, having a total worth of $1.74 million.
